Which tumor markers are associated with nonseminomatous testicular cancer?

Study for the PANCE Precision Exam. Improve with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

Which tumor markers are associated with nonseminomatous testicular cancer?

Explanation:
Nonseminomatous germ cell tumors of the testis are typically associated with two specific serum markers: AFP and beta-hCG. AFP is produced by yolk sac tumors and often by embryonal carcinoma, while beta-hCG is produced by choriocarcinoma and can be elevated in some embryonal carcinomas as well. These markers help confirm the diagnosis, guide staging and treatment planning, and monitor response or relapse during and after therapy. LDH is a non-specific marker of tumor burden and can be elevated in many conditions, including seminomas, so it’s less informative for distinguishing nonseminomatous disease. PSA, CA-125, and CEA are markers tied to other cancers or organs and are not used to characterize testicular cancer.

Nonseminomatous germ cell tumors of the testis are typically associated with two specific serum markers: AFP and beta-hCG. AFP is produced by yolk sac tumors and often by embryonal carcinoma, while beta-hCG is produced by choriocarcinoma and can be elevated in some embryonal carcinomas as well. These markers help confirm the diagnosis, guide staging and treatment planning, and monitor response or relapse during and after therapy. LDH is a non-specific marker of tumor burden and can be elevated in many conditions, including seminomas, so it’s less informative for distinguishing nonseminomatous disease. PSA, CA-125, and CEA are markers tied to other cancers or organs and are not used to characterize testicular cancer.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy